Accelerated market access for drugs and vaccines under development to combat COVID-19


One key to successfully combating COVID-19 lies in clinical research. Currently, almost all large research-based pharmaceutical manufacturers and a large number of other pharmaceutical companies and research institutions are in a global race to develop effective drugs and vaccines against the disease. Companies and institutions usually need many years to carry out preclinical and clinical research into a medicinal product or vaccine and obtain a marketing authorisation for their product.